MilliporeSigma
400 Summit Drive
Burlington, MA 01803
T: (800)-645-5476
W: www.emdmillipore.com
Twitter: @MilliporeSigma
Facebook: @MilliporeSigma
LinkedIn: www.linkedin.com/company/milliporesigma/

An Industry-Leading Portfolio of Formulation Products

Our portfolio of formulation products includes excipients for solid, semi-solid and liquid dosage forms for small and large molecules, allowing you to formulate APIs to your exact specifications and requirements. We offer customized manufacturing, formulation services and a standard portfolio of synthetic lipids and functionalized PEGs, biodegradable polymers for sustained release and functional excipients for excellent performance in tableting processes, solubility enhancement and controlled release.

Drug Delivery

Our offering for mRNA synthesis workflow includes products that can be used from generating plasmid DNA to synthesizing mRNA and finally to purifying mRNA as well as integrated CDMO capabilities that include the development and manufacturing of custom mRNAs. Our portfolio of lipids and custom lipid synthesis services help you bring your formulation to scale.

We provide high quality portfolio products as well as customized solutions to meet your specific drug delivery and formulation needs. At every phase of clinical development and commercialization, we have the resources and expertise to support your critical development milestones. We offer regulatory expertise and support to help you meet today’s complex regulatory challenges.

Liquid Formulation

Our broad portfolio of high-quality excipients for both small molecule and large molecule formulations allows you to target different administration routes such as ophthalmics, nasal, parenteral, oral, and otic preparations. Specifically developed for high-risk biopharmaceutical applications, we offer a wide range of buffers, salts and stabilizers low in bioburden and endotoxins as well as our Viscosity Reduction Platform to enable subcutaneous formulation of highly concentrated protein biologics, bringing together increased concentrations and improved downstream processing. And to help you minimize regulatory and quality-associated risks, all of our excipients are supported by extensive documentation via the industry-leading Emprove^® Program. Explore our portfolio of excipients for liquid formulation on our website.

Solid Formulation

Our high-quality raw materials and functionalized excipients form a comprehensive portfolio that addresses all your most pressing challenges in solid formulation manufacturing, with products that include: antioxidants and preservatives, binders and fillers, coatings and supporting material, disintegrants, lubricants and glidants, pH adjusters, surfactants and stabilizers, and taste modifiers.

Our particle optimized Parteck® functional excipients, for example, are specifically developed to address formulation challenges in solid dose, featuring unique particle properties and outstanding individual functionalities. The result is excellent tableting behavior and simplified formulation design, so you can speed your product to market.

In addition, you can rely on our industry-leading Emprove® Program to meet today’s complex regulatory challenges with a superior combination of comprehensive documentation and transparency. Our high-quality raw materials, regulatory expertise, and dedicated support provide everything you need to simplify supplier qualification, speed up processes, and reduce your total cost of ownership.